S
OLMA icon

SignatureFD’s Olema Pharmaceuticals OLMA Stock Holding History

SignatureFD’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-162
Closed -$944 – 3410
2024
Q4 		$944 Hold
162
– – ﹤0.01% 3043
2024
Q3 		$1.93K Hold
162
– – ﹤0.01% 2842
2024
Q2 		$1.75K Buy
+162
New +$1.76K ﹤0.01% 2791
2022
Q1 		– Sell
-680
Closed -$6K – 3266
2021
Q4 		$6K Buy
680
+576
+554% +$11.9K ﹤0.01% 2348
2021
Q3 		$3K Buy
+104
New +$2.81K ﹤0.01% 2538

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return

SignatureFD's OLMA Position: Q1 2025 in Review

SignatureFD sold out of Olema Pharmaceuticals (OLMA) in Q1 2025, closing a stake of 162 shares — an estimated $944 sold.

SignatureFD first reported a position in OLMA in Q3 2021 and held it in 5 quarters. The position peaked at $6K in Q4 2021. 133 funds tracked by Wall St. Rank hold OLMA as of Q1 2025.

  • SignatureFD reported no remaining Olema Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • SignatureFD sold 162 Olema Pharmaceuticals shares in Q1 2025, an estimated $944.
  • SignatureFD first reported a position in Olema Pharmaceuticals in Q3 2021 and held it in 5 quarters.
  • SignatureFD's Olema Pharmaceuticals position peaked at $6K in Q4 2021.
  • 133 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2025.

Based on SignatureFD's 13F filing for Q1 2025, filed 2 May 2025.